Olga Haus

Cladribine, But Not Fludarabine, Added to Daunorubicin and Cytarabine During Induction Prolongs Survival of Patients With Acute Myeloid Leukemia: A Multicenter, Randomized Phase III Study

Jerzy Hołowiecki, Sebastian Grosicki, Sebastian Giebel et al. · Journal of Clinical Oncology · 2012 · 258 citations · Full text

A high proportion of founder <i>BRCA1</i> mutations in Polish breast cancer families

Bohdan Górski, Anna Jakubowska, Tomasz Huzarski et al. · International Journal of Cancer · 2004 · 192 citations

Breast cancer predisposing alleles in Poland

Bohdan Górski, Cezary Cybulski, Tomasz Huzarski et al. · Breast Cancer Research and Treatment · 2005 · 126 citations

Allelic Variant, Breast Oncology, Genetics +5

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień et al. · Leukemia · 2004 · 125 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

Hereditary ovarian cancer in Poland

Janusz Menkiszak, Jacek Gronwald, Bohdan Górski et al. · International Journal of Cancer · 2003 · 86 citations

Brca1 Mutations, Brca1 Mutation, Hereditary Ovarian Cancer +16